About Ethris
Ethris has created a new path from genes to therapeutic proteins using its proprietary, non-immunogenic messenger RNA (mRNA) and lipidoid nanoparticle (LNP) technology platforms to discover, design and develop innovative therapies and vaccines. As an mRNA pioneer for more than a decade, our technologies enable the delivery of highly potent mRNA-based drug products directly to the upper and lower respiratory tract and via intra-muscular injection. Ethris’ differentiated platforms produce drug candidates with superior thermostability, resistance to mechanical manipulation and are nebulizable at high throughput, without change in biophysical properties or potency. We are developing our first-in-class, virus-agnostic, anti-viral treatment for COVID-19 and influenza while advancing our pipeline of immunomodulation and mRNA-based protein replacement therapies and vaccines with the ultimate goal of improving patients’ lives.
About Ethris
Ethris has paved a new path from genes to therapeutic proteins using its proprietary, non-immunogenic messenger RNA technology platform to discover, design and develop innovative therapies. With more than a decade as an mRNA pioneer, we are a global leader in delivering stabilized mRNAs directly to the respiratory system via optimized formulation and nebulization technologies. We are approaching in vivo proof of concept for generating therapeutic antibodies against COVID-19 in the lung while advancing our pipeline of immuno-modulation and mRNA-based protein replacement therapies with the ultimate goal of improving patients’ lives.
Ethris’ proprietary Stabilized Non-Immunogenic mRNA (SNIM® RNA) platform includes a toolbox of technologies to generate mRNA molecules that have low immunogenicity, maximum potency and superior production yields.
Combined with a proprietary lipidoid nanoparticle (LNP) formulation platform and a highly versatile, multi-route, multi-cargo delivery platform, Ethris is advancing a broad pipeline of mRNA-based programs for respiratory and infectious diseases as well as prophylactic vaccines.
